Avanos Medical, Inc. (AVNS) Fair Value 2026

AVNS · Orthopedic, Prosthetic & Surgical Appliances & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.0 /10

32 fundamental signals · 13 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-07-13, Avanos Medical, Inc. (AVNS) trades at $24.93, approximately 119% above CirclFi’s Bayesian DCF fair value of $11.36. QOC: 7.0/10. Value Trap Risk: 24/100 (SAFE). 13/13 models active.

Key Facts

Ticker
AVNS
Price
$24.93
Quality Score
7.0/10
Value Trap Risk
24/100
Models Active
13/13
Last Updated
Strength: Earnings Power Value suggests +47.0% upside with 26% confidence
Risk: Majority of models suggest overvaluation

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($24.93)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$11.36 -54.4%
Earnings Power Value
Medium Conviction
$36.64 +47.0%
CUCE Ensemble
Low Conviction
$20.46 -17.9%
First Chicago
High Conviction
$9.00 -63.9%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Avanos Medical, Inc. (AVNS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Avanos Medical, Inc.'s intrinsic value is estimated at a composite $20.43, showing conflicting signals at the current price of $24.93. While the average implied return is -18.1%, model disagreement is elevated with a gap of +139.6% between the most bullish and bearish estimates. The most optimistic model, EPV, places fair value at $36.64 (+47.0%), while Markov DDM — the most conservative — estimates $1.84 (-92.6%). This +139.6% gap reflects genuine analytical uncertainty about Avanos Medical, Inc.'s intrinsic worth.

What Do the Models Say About AVNS?

13 of 13 models are currently active for AVNS. Of these, 5 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates AVNS's intrinsic value at $11.36, implying -54.4% downside from the current price. See which stocks rank higher →

How Does AVNS Rank in Orthopedic, Prosthetic & Surgical Appliances & Supplies?

Among 27 Orthopedic, Prosthetic & Surgical Appliances & Supplies stocks, AVNS ranks #9 by Quality of Company score. CirclFi's QOC score of 7.0/10 evaluates 32 fundamental signals. A score of 7.0 indicates above-average quality.

Avanos Medical, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is AVNS a Value Trap?

CirclFi's Value Trap algorithm assigns AVNS a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Avanos Medical, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Avanos Medical, Inc. scores 7.0 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +139.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AVNS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across AVNS's 13 active models, average confidence is 36%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Avanos Medical, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Orthopedic, Prosthetic & Surgical Appliances & Supplies Stocks Should You Also Analyze?

8 related Orthopedic, Prosthetic & Surgical Appliances & Supplies stocks with 13-model coverage

Read investment analysis: STE · ISRG · EW · MSA · CDRE

Frequently Asked Questions About Avanos Medical, Inc.

What is Avanos Medical, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Avanos Medical, Inc. (AVNS) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $11.36. The Quality of Company score is 7.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AVNS overvalued or undervalued right now?

At $24.93, 5 of 13 active models suggest AVNS may be undervalued, while 8 indicate potential overvaluation. The assessment depends on which methodology best fits Avanos Medical, Inc.'s business model in Orthopedic, Prosthetic & Surgical Appliances & Supplies.

What does a Quality of Company score of 7.0 mean for AVNS?

Avanos Medical, Inc.'s QOC of 7.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on AVNS?

CirclFi analyzes AVNS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is AVNS a value trap in 2026?

Avanos Medical, Inc.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on AVNS.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access